| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive‐disease small cell lung cancer
|
Salgia, Ravi
|
|
2017
|
105 |
C |
p. 7-13
7 p.
|
artikel
|
| 2 |
Circulating heregulin level is associated with the efficacy of patritumab combined with erlotinib in patients with non-small cell lung cancer
|
Yonesaka, Kimio
|
|
2017
|
105 |
C |
p. 1-6
6 p.
|
artikel
|
| 3 |
Contents
|
|
|
2017
|
105 |
C |
p. iv-
1 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2017
|
105 |
C |
p. iii-
1 p.
|
artikel
|
| 5 |
Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition
|
Le, Tri
|
|
2017
|
105 |
C |
p. 14-16
3 p.
|
artikel
|
| 6 |
Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?
|
Mansfield, Aaron Scott
|
|
2017
|
105 |
C |
p. 49-51
3 p.
|
artikel
|
| 7 |
Patients with lung cancer: Are electronic cigarettes harmful or useful?
|
Dautzenberg, Bertrand
|
|
2017
|
105 |
C |
p. 42-48
7 p.
|
artikel
|
| 8 |
Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer
|
Katakami, Nobuyuki
|
|
2017
|
105 |
C |
p. 23-30
8 p.
|
artikel
|
| 9 |
Pilot study on use of home telephoning to identify and recruit high-risk individuals for lung cancer screening
|
Veronesi, Giulia
|
|
2017
|
105 |
C |
p. 39-41
3 p.
|
artikel
|
| 10 |
Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients
|
Gachechiladze, Mariam
|
|
2017
|
105 |
C |
p. 31-38
8 p.
|
artikel
|
| 11 |
Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer
|
Soo, Ross A.
|
|
2017
|
105 |
C |
p. 17-22
6 p.
|
artikel
|
| 12 |
What is the optimal radiotherapy schedule for limited stage small cell lung cancer?
|
Slotman, Ben
|
|
2017
|
105 |
C |
p. 52-53
2 p.
|
artikel
|
Tijdschrift beschrijving